Safety and compliance of intravenous and oral dosing regimens.
Jackson
Graham
G
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000517:prevention & control* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008297:Male; D009017:Morbidity; D010349:Patient Compliance; D011471:Prostatic Neoplasms / Q000473:pathology; D012307:Risk Factors
D004164:Diphosphonates